Concomitant use of dronedarone with dabigatran in patients with atrial fibrillation in clinical practice.

Natalia Mochalina; Tord Juhlin; Pyotr Platonov; Peter Svensson; Mattias Wieloch

doi:10.1016/j.thromres.2015.03.015

Concomitant use of dronedarone with dabigatran in patients with atrial fibrillation in clinical practice.

Natalia Mochalina, Tord Juhlin, Pyotr Platonov, Peter Svensson, Mattias Wieloch

Research output: Contribution to journal › Article › peer-review

Abstract

Dronedarone is a strong P-glycoprotein inhibitor with a potential to increase bioavailability of dabigatran. We sought to measure and report plasma concentrations of dabigatran in patients with atrial fibrillation (AF) on concomitant dronedarone treatment.

Original language	English
Pages (from-to)	1070-1074
Journal	Thrombosis Research
Volume	135
Issue number	6
DOIs	https://doi.org/10.1016/j.thromres.2015.03.015
Publication status	Published - 2015

Subject classification (UKÄ)

Cardiology and Cardiovascular Disease

Access to Document

10.1016/j.thromres.2015.03.015

http://www.ncbi.nlm.nih.gov/pubmed/25842008?dopt=Abstract

1 Doctoral Thesis (compilation)

Anticoagulant and antiarrhythmic agents for atrial fibrillation
Mochalina, N., 2017, Lund: Lund University: Faculty of Medicine. 81 p.
Research output: Thesis › Doctoral Thesis (compilation)

Open Access
File

Cite this

@article{d90f25b79bb446ef8152fc1980207a56,

title = "Concomitant use of dronedarone with dabigatran in patients with atrial fibrillation in clinical practice.",

abstract = "Dronedarone is a strong P-glycoprotein inhibitor with a potential to increase bioavailability of dabigatran. We sought to measure and report plasma concentrations of dabigatran in patients with atrial fibrillation (AF) on concomitant dronedarone treatment.",

author = "Natalia Mochalina and Tord Juhlin and Pyotr Platonov and Peter Svensson and Mattias Wieloch",

year = "2015",

doi = "10.1016/j.thromres.2015.03.015",

language = "English",

volume = "135",

pages = "1070--1074",

journal = "Thrombosis Research",

issn = "1879-2472",

publisher = "Elsevier",

number = "6",

}

TY - JOUR

T1 - Concomitant use of dronedarone with dabigatran in patients with atrial fibrillation in clinical practice.

AU - Mochalina, Natalia

AU - Juhlin, Tord

AU - Platonov, Pyotr

AU - Svensson, Peter

AU - Wieloch, Mattias

PY - 2015

Y1 - 2015

N2 - Dronedarone is a strong P-glycoprotein inhibitor with a potential to increase bioavailability of dabigatran. We sought to measure and report plasma concentrations of dabigatran in patients with atrial fibrillation (AF) on concomitant dronedarone treatment.

AB - Dronedarone is a strong P-glycoprotein inhibitor with a potential to increase bioavailability of dabigatran. We sought to measure and report plasma concentrations of dabigatran in patients with atrial fibrillation (AF) on concomitant dronedarone treatment.

U2 - 10.1016/j.thromres.2015.03.015

DO - 10.1016/j.thromres.2015.03.015

M3 - Article

C2 - 25842008

SN - 1879-2472

VL - 135

SP - 1070

EP - 1074

JO - Thrombosis Research

JF - Thrombosis Research

IS - 6

ER -

Concomitant use of dronedarone with dabigatran in patients with atrial fibrillation in clinical practice.

Abstract

Subject classification (UKÄ)

Access to Document

Fingerprint

Research output

Anticoagulant and antiarrhythmic agents for atrial fibrillation

Cite this